Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A

Strategies for extended serum half-life of protein therapeutics

(2011) Roland E Kontermann   CURRENT OPINION IN BIOTECHNOLOGY

TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP-1, and downstream gene transcription

(2010) Anna Claßen et al.   EXPERIMENTAL DERMATOLOGY

Albinterferon-alfa 2b: a new treatment option for hepatitis C

(2010) Robert Flisiak et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses

(2010) Maria Evangelidou et al.   IMMUNOLOGY AND CELL BIOLOGY

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

(2010) Jan Terje Andersen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Delivery of Therapeutic Proteins

(2010) Dipak S. Pisal et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Humanization of a Mouse Monoclonal Antibody Directed Against a Cell Surface-Exposed Epitope of Membrane-Associated Heat Shock Protein 70 (Hsp70)

(2010) Kirstin A. Zettlitz et al.   MOLECULAR BIOTECHNOLOGY

The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein

(2010) J. Hopp et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Strategies to Extend Plasma Half-Lives of Recombinant Antibodies

(2009) Roland E. Kontermann   BIODRUGS

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology

(2009) Chichi Huang   CURRENT OPINION IN BIOTECHNOLOGY

Engineered protein scaffolds as next-generation antibody therapeutics

(2009) Michaela Gebauer et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives

(2009) Roland Stork et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Display scaffolds: protein engineering for novel therapeutics

(2008) S NUTTALL et al.   CURRENT OPINION IN PHARMACOLOGY